Skip to main content
Clinical Trials/ISRCTN53570733
ISRCTN53570733
Completed
N/A

Observational cohort study to evaluate the safety of agomelatine in standard medical practice in depressed patients: a prospective, observational (non interventional), international, multicentre cohort study

Institut de Recherches Internationales Servier (France)0 sites1,484 target enrollmentAugust 27, 2010

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Institut de Recherches Internationales Servier (France)
Enrollment
1484
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

2020 results in https://pubmed.ncbi.nlm.nih.gov/32729068/ (added 03/08/2020) 2020 results in https://pubmed.ncbi.nlm.nih.gov/32976677/ (added 28/09/2020)

Registry
who.int
Start Date
August 27, 2010
End Date
March 12, 2015
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Institut de Recherches Internationales Servier (France)

Eligibility Criteria

Inclusion Criteria

  • 1\. Both genders patients aged at least 18 years or legal age of majority (without upper limit of age)
  • 2\. Initiated into agomelatine for their current depressive episode
  • 3\. Having signed an informed consent

Exclusion Criteria

  • 1\. Having to stop an ongoing antidepressant with which they were treated with success for their depression
  • 2\. Already treated with another antidepressant that they wish to continue in addition to agomelatine
  • 3\. Planning to move during the 26 weeks of the follow\-up

Outcomes

Primary Outcomes

Not specified

Similar Trials